HRP20120682T1 - Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina - Google Patents
Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina Download PDFInfo
- Publication number
- HRP20120682T1 HRP20120682T1 HRP20120682TT HRP20120682T HRP20120682T1 HR P20120682 T1 HRP20120682 T1 HR P20120682T1 HR P20120682T T HRP20120682T T HR P20120682TT HR P20120682 T HRP20120682 T HR P20120682T HR P20120682 T1 HRP20120682 T1 HR P20120682T1
- Authority
- HR
- Croatia
- Prior art keywords
- seq
- fragments
- composition
- use according
- alone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/265—Enterobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20040147A CU23475A1 (es) | 2004-07-08 | 2004-07-08 | Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas |
| PCT/CU2005/000003 WO2006005268A2 (fr) | 2004-07-08 | 2005-07-05 | Composition pharmaceutique contenant des fragments polypeptidiques de serralysine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120682T1 true HRP20120682T1 (hr) | 2012-09-30 |
Family
ID=40259088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120682TT HRP20120682T1 (hr) | 2004-07-08 | 2005-07-05 | Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8076297B2 (fr) |
| EP (1) | EP1787653B1 (fr) |
| JP (1) | JP4914350B2 (fr) |
| KR (1) | KR101365056B1 (fr) |
| AR (1) | AR050255A1 (fr) |
| AU (1) | AU2005262159B2 (fr) |
| BR (1) | BRPI0513136A (fr) |
| CA (1) | CA2572984C (fr) |
| CU (1) | CU23475A1 (fr) |
| CY (1) | CY1114201T1 (fr) |
| DK (1) | DK1787653T3 (fr) |
| ES (1) | ES2389126T3 (fr) |
| HR (1) | HRP20120682T1 (fr) |
| MX (1) | MX2007000339A (fr) |
| MY (1) | MY150858A (fr) |
| PL (1) | PL1787653T3 (fr) |
| PT (1) | PT1787653E (fr) |
| RS (1) | RS52448B (fr) |
| RU (1) | RU2396274C2 (fr) |
| SI (1) | SI1787653T1 (fr) |
| WO (1) | WO2006005268A2 (fr) |
| ZA (1) | ZA200700178B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2378777T3 (es) * | 2004-11-23 | 2012-04-17 | Zymogenetics, Inc. | Purificación del factor XIII humano recombinante |
| CN101675355B (zh) | 2007-05-04 | 2017-04-19 | 皇家飞利浦电子股份有限公司 | 具有对由mr线圈导致的辐射吸收进行校正的混合mr/pet |
| CU23950B1 (es) | 2011-03-21 | 2013-10-29 | Ct De Ingeniería Genética Y Biotecnología | Péptidos cíclicos con actividad antineoplásica y antiangiogénica |
| TWI746449B (zh) * | 2015-07-20 | 2021-11-21 | 美商Ａｉ治療公司 | 使用阿吡莫德治療癌症之方法 |
| CN109295041A (zh) * | 2018-10-10 | 2019-02-01 | 宁波希诺亚海洋生物科技有限公司 | 具有舍雷肽酶活性的多肽及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58134991A (ja) * | 1981-12-28 | 1983-08-11 | Takeda Chem Ind Ltd | セラチオペプチタ−ゼの安定化法 |
| JP2611206B2 (ja) * | 1985-11-15 | 1997-05-21 | 武田薬品工業株式会社 | 遺伝子およびその利用方法 |
| KR100252197B1 (ko) * | 1997-09-20 | 2000-04-15 | 박호군 | 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신 |
| RU2229305C2 (ru) * | 1998-04-15 | 2004-05-27 | Лексиген Фармасьютикэлс Корпорейшн | Усиление иммунных ответов, опосредованных белками, слитыми из антитела и цитокина, посредством совместного введения ингибитора ангиогенеза |
| US20040185566A1 (en) | 2003-03-19 | 2004-09-23 | Peter Salamone | Polypeptides toxic to nematodes and methods of use |
-
2004
- 2004-07-08 CU CU20040147A patent/CU23475A1/es unknown
-
2005
- 2005-07-05 RS RS20120391A patent/RS52448B/sr unknown
- 2005-07-05 RU RU2007104776/13A patent/RU2396274C2/ru not_active IP Right Cessation
- 2005-07-05 DK DK05762122.9T patent/DK1787653T3/da active
- 2005-07-05 AU AU2005262159A patent/AU2005262159B2/en not_active Ceased
- 2005-07-05 MX MX2007000339A patent/MX2007000339A/es active IP Right Grant
- 2005-07-05 JP JP2007519599A patent/JP4914350B2/ja not_active Expired - Fee Related
- 2005-07-05 EP EP05762122A patent/EP1787653B1/fr not_active Expired - Lifetime
- 2005-07-05 US US11/631,880 patent/US8076297B2/en not_active Expired - Fee Related
- 2005-07-05 PT PT05762122T patent/PT1787653E/pt unknown
- 2005-07-05 PL PL05762122T patent/PL1787653T3/pl unknown
- 2005-07-05 SI SI200531578T patent/SI1787653T1/sl unknown
- 2005-07-05 KR KR1020077002589A patent/KR101365056B1/ko not_active Expired - Fee Related
- 2005-07-05 BR BRPI0513136-7A patent/BRPI0513136A/pt not_active Application Discontinuation
- 2005-07-05 CA CA2572984A patent/CA2572984C/fr not_active Expired - Fee Related
- 2005-07-05 WO PCT/CU2005/000003 patent/WO2006005268A2/fr not_active Ceased
- 2005-07-05 HR HRP20120682TT patent/HRP20120682T1/hr unknown
- 2005-07-05 ES ES05762122T patent/ES2389126T3/es not_active Expired - Lifetime
- 2005-07-07 MY MYPI20053102 patent/MY150858A/en unknown
- 2005-07-08 AR ARP050102834A patent/AR050255A1/es active IP Right Grant
-
2007
- 2007-01-05 ZA ZA200700178A patent/ZA200700178B/xx unknown
-
2012
- 2012-09-05 CY CY20121100800T patent/CY1114201T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0513136A (pt) | 2008-04-29 |
| ES2389126T3 (es) | 2012-10-23 |
| JP2008505129A (ja) | 2008-02-21 |
| CA2572984C (fr) | 2014-12-09 |
| RU2396274C2 (ru) | 2010-08-10 |
| EP1787653A2 (fr) | 2007-05-23 |
| KR101365056B1 (ko) | 2014-02-21 |
| PT1787653E (pt) | 2012-09-06 |
| US20110218138A1 (en) | 2011-09-08 |
| CY1114201T1 (el) | 2016-08-31 |
| EP1787653B1 (fr) | 2012-06-06 |
| MY150858A (en) | 2014-03-14 |
| RS52448B (sr) | 2013-02-28 |
| DK1787653T3 (da) | 2012-09-17 |
| ZA200700178B (en) | 2008-06-25 |
| MX2007000339A (es) | 2007-03-12 |
| WO2006005268A3 (fr) | 2006-03-09 |
| AU2005262159A1 (en) | 2006-01-19 |
| CA2572984A1 (fr) | 2006-01-19 |
| SI1787653T1 (sl) | 2012-10-30 |
| KR20070042542A (ko) | 2007-04-23 |
| AR050255A1 (es) | 2006-10-11 |
| AU2005262159B2 (en) | 2011-08-18 |
| PL1787653T3 (pl) | 2012-11-30 |
| US8076297B2 (en) | 2011-12-13 |
| CU23475A1 (es) | 2009-12-17 |
| JP4914350B2 (ja) | 2012-04-11 |
| RU2007104776A (ru) | 2008-08-20 |
| WO2006005268A2 (fr) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Passalacqua et al. | Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation | |
| Vink et al. | B cell growth and differentiation activity of interleukin‐HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1 | |
| BR0306979A (pt) | Polipeptìdeo isolado, proteìna de fusão, molécula isolada de polinucleotìdeo, vetor de expressão, célula cultivada, anticorpo ou fragmento de anticorpo, e, métodos para produzir uma proteìna, para produzir um anticorpo, para estimular uma resposta imune em um mamìfero, para expandir células hematopoiéticas e progenitores de células hematopoiéticas, para detectar a presença de rna zcytor17lig e de zcytor17lig em uma amostra biológica, para matar cérlulas cancerìgenas, para inibir a proliferação induzida por zcytor17lig ou diferenciação de células hematopoiéticas e progenitoras de células hematopoiéticas, para reduzir a inflamação induzida por zcytor17lig para suprimir uma resposta inflamatória em um mamìfero com inflamação, para tratar um mamìfero acometido por uma doença inflamatória e para detectar inflamação em um paciente | |
| Nakaji-Hirabayashi et al. | Hyaluronic acid hydrogel loaded with genetically-engineered brain-derived neurotrophic factor as a neural cell carrier | |
| Ding et al. | Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF | |
| BRPI0612273A2 (pt) | anticorpo de ligaÇço a il-1 beta ou fragmento de ligaÇço a il-1 beta do mesmo, Ácido nucleico, vetor, cÉlula, animal transgÊnico, hibridoma, composiÇço, e, mÉtodos de tratamento ou prevenÇço de uma doenÇa ou doenÇa relacionada a il-1 em um mamÍfero, e de preparaÇço de um polipeptÍdeo de ligaÇço a il-1 beta maturado por afinidade | |
| IL264439B1 (en) | non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment | |
| CA2976376A1 (fr) | Produits d'acides nucleiques et leurs procedes d'administration | |
| Souza et al. | Regeneration of skin tissue promoted by mesenchymal stem cells seeded in nanostructured membrane | |
| DE60028830D1 (de) | Anti-april antikörper und hybridomazellen | |
| CN112679615B (zh) | 一种融合蛋白 | |
| Wang et al. | Macrophage-derived oncostatin M/bone morphogenetic protein 6 in response to Mg-based materials influences pro-osteogenic activity of human umbilical cord perivascular cells | |
| EP3587440B1 (fr) | Peptide humain à haute affinité aux protéines pd-l1 et son utilisation | |
| US20100112031A1 (en) | Compositions And Methods For Regulating Extracellular Matrix Production In Adipose Derived Cells | |
| You et al. | The effects of cerium valence states at cerium oxide coatings on the responses of bone mesenchymal stem cells and macrophages | |
| CZ20031570A3 (cs) | Nové fibroblastové růstové faktory a farmaceutické přípravky, které je obsahují | |
| Yoon et al. | The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells | |
| Li et al. | Tenascin C affects mineralization of SaOS2 osteoblast-like cells through matrix vesicles | |
| BRPI0515604A (pt) | método para o tratamento de células de cáncer e método de tratamento de uma doença imune relacionada | |
| HRP20120682T1 (hr) | Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina | |
| Achour et al. | Pleiotrophin induces expression of inflammatory cytokines in peripheral blood mononuclear cells | |
| Roy et al. | Construction and stable gene expression of AGR2xPD1 bi-specific antibody that enhances attachment between T-Cells and lung tumor cells, suppress tumor cell migration and promoting CD8 expression in cytotoxic T-cells | |
| Huang et al. | Neuron localization and neuroblastoma cell expression of brain-derived growth factor | |
| CN107354128A (zh) | 一种鹿茸多肽的促成骨转化用途 | |
| Shcheglovitova et al. | Cow milk angiogenin induces cytokine production in human blood leukocytes |